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Introduction
Human endocrine systems such as the thyroid 
are susceptible to disruption by naturally 
occurring and human-made compounds, 
possibly by affecting the hormone homeo-
stasis. Endocrine-disrupting abilities have 
been suggested for persistent organic pollut-
ants (POPs), of which two major groups 
are perfluoroalkyl substances (PFASs) and 
organochlorines (OCs). POPs are persistent 
substances that have been emitted to the envi-
ronment (Lohmann et al. 2007; Prevedouros 
et al. 2006). Still, PFASs and OCs have 
different chemical properties and histories of 
production and use. Diet is suspected to be the 
major current exposure pathway to POPs for 
humans (Malisch and Kotz 2014; Vestergren 
and Cousins 2009). In addition, PFASs are 
passed to humans through air, house dust, 
drinking water, and water-based beverages 
(Eschauzier et al. 2013; Haug et al. 2011; 
Ullah et al. 2011).
Disruption of thyroid homeostasis 
following POP exposure has been observed in 
animal experiments and indicated in human 
studies (Boas et al. 2012). Influence on the 
maternal thyroid system by POPs is of special 
interest during pregnancy because such effects 
could delay and impair fetal and neonatal 
development (Massart and Meucci 2007). 
The thyroid endocrine system is critical for 
regulating energy homeostasis, metabolic 
pathways, and the growth and differen-
tiation of many tissues and organs. Thyroid-
stimulating hormone (TSH) regulates the 
production of the thyroid hormones (THs), 
triiodothyronine (T3), and thyroxine (T4). 
Maternal T4 is the sole source of TH to the 
developing fetal brain before the onset of 
the fetal thyroid function at approximately 
20 weeks gestation (Morreale de Escobar 
et al. 2004). The fetus is still dependent on 
maternal THs throughout the gestational 
period, and inadequate transfer of these may 
alter thyroid homeostasis in infants also the 
first weeks after birth (Blackburn 2013).
The major metabolic processes (e.g., 
metabolism of fat, glucose, protein, and micro-
nutrients) increase during the pregnancy along 
with an expansion of blood volume, to meet 
the demand of uterus and fetal development. 
During the first two trimesters of pregnancy, 
there are marked changes in the maternal 
hypothalamic–pituitary–thyroid (HTP) axis 
to increase the availability of THs in blood. 
In short, these changes lead to a 2- to 3-fold 
increase in thyroid hormone–binding proteins 
(TH-BPs), and a subsequent decrease in levels 
of free thyroxine (FT4) and free triiodothyro-
nine (FT3) followed by an increased produc-
tion of T3 and T4. Changes in individual TH 
levels throughout pregnancy vary by gesta-
tional age, number of fetuses, and study popu-
lation, but generally, the woman achieves a 
new steady state in HTP function at the end 
of the second trimester that is maintained 
until delivery (Blackburn 2013). Pregnancy-
induced changes in thyroid physiology affect 
laboratory interpretation, and presently there 
are no universally accepted reference ranges 
(Fitzpatrick and Russell 2010).
The potential influence on thyroid 
homeostasis by POPs in background exposed 
populations are of interest, especially if POPs 
can mimic or inhibit the response of natural 
hormones even at low doses (Vandenberg 
et al. 2012). Linear effects of many hormones 
exist up to a dose that occupies about 10% 
of receptors; at higher doses, occupancy rate 
does not linearly increase as the dose of the 
hormone increases (Welshons et al. 2003). 
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Background: Disruption of thyroid homeostasis has been indicated in human studies targeting 
effects of persistent organic pollutants (POPs). Influence on the maternal thyroid system by POPs 
is of special interest during pregnancy because such effects could impair infant thyroid homeostasis.
oBjectives: We investigated the association between POPs and thyroid-stimulating hormone 
(TSH) and thyroid hormones (THs) in mother and child pairs from the Northern Norway Mother-
and-Child Contaminant Cohort Study (MISA).
Methods: Nineteen POPs and 10 thyroid parameters were analyzed in serum from 391 pregnant 
women in their second trimester. In addition, TSH concentrations in heel-prick samples from the 
infants were analyzed by the Norwegian Newborn Screening program. Association studies with a 
multipollutant approach were performed using multivariate analyses; partial least squares (PLS) 
regression, hierarchical clustering, and principal component analysis (PCA).
results: Several POPs were significantly associated with TSH and THs: a) PFOS was positively 
associated with TSH; b) PCBs, HCB, and nonachlors were inversely associated with T3, T4, and 
FT4; and, c) PFDA and PFUnDA were inversely associated with T3 and FT3. After mutual adjust-
ments for the other contaminants, only PFDA and PFUnDA remained significantly associated with 
T3 and FT3, respectively. Infants born to mothers within the highest TSH quartile had 10% higher 
mean concentrations of TSH compared with children born to mothers in the lowest TSH quartile.
conclusion: The present results suggest that background exposures to POPs can alter maternal 
thyroid homeostasis. This research contributes to the understanding of multipollutant exposures 
using multivariate statistical approaches and highlights the complexity of investigating environ-
mental concentrations and mixtures in regard to maternal and infant thyroid function.
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Similarly, some POPs might be more potent 
endocrine disruptors at low concentrations 
(Ruzzin et al. 2010). Therefore, the present 
study aimed to perform a multipollutant 
assessment of the effect of background expo-
sures of POPs on thyroid homeostasis in 
mother–child pairs in Northern Norway.
Materials and Methods
Study Participants and Collection 
of Blood Samples
The selected subjects in the present study were 
391 mother–child pairs from the Northern 
Norway Mother-and-Child Contaminant 
Cohort Study (MISA), which consists of 515 
enrolled pregnant women recruited from May 
2007 to June 2009. The 391 participants 
with complete data sets consisting of maternal 
serum concentrations of PFASs, OCs, thyroid 
parameters, and infant TSH concentrations 
were initially included in the study. Women 
with self-reported thyroid-related disease 
(n = 16) and/or twin pregnancy (n = 6) were 
excluded and 370 mother–child pairs were 
included in the statistical analyses. The mothers 
answered a detailed questionnaire about diet 
and lifestyle at enrollment, and donated a 
blood sample during their second trimester 
(median, gestational week 18). The women 
were requested to fast or eat a light, nonfatty 
breakfast no later than 2 hr before the blood 
sampling. Blood samples of infants were 
collected 3 days after birth. Detailed informa-
tion about the study group characteristics, 
ethics approvals, the food frequency question-
naire (FFQ), and the blood collection proce-
dures have been reported elsewhere (Hansen 
et al. 2010; Veyhe et al. 2012). Planning of the 
project took place in 2006, and approvals were 
obtained from the Regional Committee for 




Blood samples were analyzed for a broad 
selection of PFASs. A total of 26 PFASs were 
initially screened for in a subgroup of 50 serum 
samples. Compounds detected above the limit 
of detection (LOD) in > 20% of the samples 
were further quantified in all serum samples. 
Detailed information about the compounds, 
sample preparation, extraction method, analyt-
ical method, reagents, and instrumentation 
has been reported elsewhere (Berg et al. 2014; 
Hanssen et al. 2013). Briefly, PFASs were 
determined in serum samples using sonication-
facilitated liquid–liquid extraction, activated 
ENVI-Carb™ (Sigma Aldrich) cleanup (Powley 
et al. 2005) and analyzed by ultrahigh-pressure 
liquid chromatography triple–quadrupole 
mass-spectrometry (UHPLC-MS/MS).
OC Analyses
The methods employed for the OC analyses 
have been described in detail in Hansen et al. 
(2010). Briefly, internal standards, formic 
acid, and deionized water were added to 2 mL 
serum sample and left in the refrigerator over-
night before being extracted through an HLB 
solid-phase extraction (SPE) column using 
dichloromethane. Further cleanup involved 
elution of compounds from Florisil columns 
with n-hexane/dichloromethane. OCs were 
identified and quantified in the extracts with 
a gas chromatograph/mass spectrometer 
operated in electron impact mode. Assessment 
of isotopic mass ratios, blank samples, and 
standard reference materials ensured the 
quality of the results. Finally, lipids were deter-
mined enzymatically, and the summed amount 
of lipids was calculated as described by Akins 
et al. (1989).
The quality of the PFAS and OC analyses 
was assured through repetitive analysis of blank 
samples and reference samples. Additionally, 
our laboratory participates in the international 
Artic Monitoring and Assessment Programme 
ring test for POPs in human serum (Institut 
national de santé publique du Québec 2014). 
Interlaboratory comparisons and reference 
samples indicate that the uncertainties of our 
analyses are within ± 15–20% of the assigned 
values. Further details on quality control issues 
have been published elsewhere (Berg et al. 2014; 
Hansen et al. 2010). The linear perfluorooctane 
sulfonate (PFOS) isomers were chromatographi-
cally separated from the branched isomers and 
quantified separately. Summed concentrations 
of isomers were used in the statistical analyses.
TH and TH-BP Analyses
Determination of maternal THs, TH-BPs 
[thyroxine-binding globulin (TBG), trans-
thyretin (TTR) and albumin], thyroxine-
binding capacity, and anti-TPO (thyroid 
peroxidase antibody) concentrations serum 
samples were performed by laboratory staff at 
the University Hospital of Northern Norway. 
The analyses are routine analyses used in the 
clinic for diagnostic purposes except for T3, 
T4, and thyroxine-binding capacity. Analytical 
methods, instrumentation, analytical variation, 
quality controls, and method specific refer-
ence ranges have been reported by Berg et al. 
(2015). The laboratory is certified according to 
ISO 151810 (Norwegian Accreditation 2014). 
The Norwegian National Unit for Newborn 
Screening at Oslo University Hospital tested 
the newborn blood for TSH concentrations. 
Blood spots were collected on an S&S or 
Whatman 903 filter paper and analysed with 
Autodelfia neonatal TSH kits (PerkinElmer).
Statistical Analyses
Statistical analyses were performed using 
SPSS statistic software, version 22 (IBM 
SPSS Inc., Chicago, IL, USA) and R (version 
3.1.1; R Project for Statistical Computing). 
A statistical significance threshold of 
p < 0.05 was used. Only POPs with detec-
tion frequencies > 80% were evaluated in 
statistical models, and concentrations below 
LODs were replaced by the LOD divided 
by the square root of 2. All POP concentra-
tions, TSH, and THs were log-normally 
distributed (Shapiro–Wilk tests) and therefore 
log10-transformed in the statistical analyses. 
Spearman’s ρ values were calculated for corre-
lations. Statistical analyses were performed 
including POPs as ng/mL concentrations 
and repeated using mmol/L concentrations. 
Initially, partial least square (PLS) regressions 
were used to evaluate the impact of all POPs 
and potential covariates simultaneously on 
maternal serum concentrations of TSH and 
THs. Separate PLS models were performed 
with log10-transformed and standardized 
(z-scores) variables. For data reduction and 
to increase the model predictive ability, only 
variables with variable importance to projec-
tion (VIP) values > 0.4 were included in the 
final model. For highly correlated covari-
ates sensitive to pregnancy-related changes, 
principal components analysis (PCA) was 
performed. The score of each woman on the 
first principal component was included as a 
common pregnancy vector in multiple linear 
regression models to avoid collinearity issues 
while adjusting for these factors. To minimize 
the number of contaminants to be included 
in linear regression models, hierarchical clus-
tering analysis of POPs based on correlations 
(method: complete linkage) was performed, 
and groupings according to clusters were 
subsequently performed by simple addition 
of POP concentrations. Finally, contaminants 
(individual, grouped or summed, as ng/mL or 
mmol/L, assessed as quartiles) and covariates 
were included in multiple linear regression 
models to report the strength of associations 
between POPs with TSH and THs. Separate 
models were built for five dependent vari-
ables—TSH, T3, T4, FT3, and FT4—where 
the number of subjects varied between models 
(n = 360–370) according to complete infor-
mation sets. Diagnostic plots of the residuals 
and potential influential points were evalu-
ated. Possible confounders were controlled by 
stratification on variables correlated to both 
PFOS and THs (results not shown).
Results
Population Characteristics
Demographic characteristics of the pregnant 
women are summarized in Table 1, which 
shows the variables used as covariates in final 
statistical models. Characteristics for other vari-
ables evaluated as covariates (including iodine 
status) were decribed in Berg et al. (2015). 
POPs and thyroid function in mother–child pairs
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Demographic characteristics of the newborns 
are presented in Table 2, which includes avail-
able clinical data. The included subjects are 
representative for pregnant women from the 
geographical region. The demographic char-
acteristics of the MISA study population and 
comparison to the general Norwegian pregnant 
population are reported in detail by Veyhe 
et al. (2012).
Contaminant Concentrations and 
their Correlations
Seven PFASs were detected in more than 
80% of blood samples and were included 
in the statistical analyses; PFOS (median of 
8.03 ng/mL) was the dominating compound, 
followed by perfluorooctanoate (PFOA, 
1.53 ng/mL), perfluorononanoate (PFNA, 
0.56 ng/mL), perfluorohexane sulfonate 
(PFHxS, 0.44 ng/mL), perfluoroundecanoate 
(PFUnDA, 0.26 ng/mL), perfluorodecanoate 
(PFDA, 0.23 ng/mL), and perfluorohep-
tane sulfonate (PFHpS, 0.10 ng/mL). PFAS 
concentrations and their predictors are 
described in detail elsewhere (Berg et al. 2014).
Eight polychlorinated biphenyls (PCBs) 
and four pesticides were detected in > 80% of 
blood samples and included in the statistical 
analyses (see Table S1). The highest median 
wet-weight concentrations were found for 
p,p´-dichlorodiphenyldichloroethylene 
(p,p´-DDE, 0.24 ng/g) followed by PCB-153 
(0.16 ng/g), PCB-180 (0.11 ng/g), PCB-138 
(0.09 ng/g), hexachlorobenzene (HCB, 
0.06 ng/g), PCB-170 (0.04 ng/g), PCB-187 
(0.03 ng/g), PCB-118 (0.03 ng/g), PCB-163 
(0.02 ng/g), trans-nonachlor (0.02 ng/g), 
PCB-99 (0.01 ng/g), and cis-nonachlor 
(0.004 ng/g). OC concentrations in the entire 
study population and predictors are described 
in detail by Veyhe et al. (2015).
The OCs intragroup correlations were 
higher within the OCs (r = 0.54–0.95) 
compared with the PFASs (r = 0.19–0.75) 
(see Table S2). In the hierarchical clustering 
analysis, the PCBs were separated in two 
separate groups and cis- and trans-nonachlors 
into one group (see Figure S1). The corre-
lations between the OCs and the PFASs 
were low and ranged from r = 0.13 to 0.50 
where the longest chained PFASs were more 
correlated to the OCs than were the shorter 
chained compounds.
Concentrations of Maternal TSH, 
THs, and TH-BPs and Infant TSH
Maternal concentrations of TSH, THs, and 
TH-BPs were within nonpregnant refer-
ence ranges (Table 1) and time of blood 
sampling during the day did not influ-
ence the variance in concentrations between 
participants. Twenty-two women had thyroid 
peroxidase antibodies > 34 IU/L and were 
categorized as anti-TPO positive according 
to the manufacturer. The anti-TPO positive 
women were included in all analyses, tables, 
and figures because results were unchanged if 
excluding them. Concentrations of infant TSH 
are presented in Table 2. The ranges of infant 
TSH levels were within what is considered a 
normal reference range (Kapelari et al. 2008). 
Four infants could be classified with subclinical 
hypothyroidism as characterized by TSH 
concentrations > 5 mlU/L (Kaplowitz 2010).
Maternal TH Concentrations 
and Associations with POP 
Concentrations
PLS regression indicated positive associations 
between maternal concentrations of TSH and 
most PFASs and OCs (Figure 1). Further, 
parity and thyroxine-binding capacity were 
important covariates for TSH concentrations. 
The PLS regression also demonstrated an 
inverse relationship of several OCs, PFDA, and 
PFUnDA with the THs (Figure 1). Important 
covariates for these THs were variables related 
to the course of pregnancy: lipids, albumin, 
TBG, TTR, thyroxine-binding capacity, and 
gestational week and these were highly corre-
lated. In the PCA, 50% of the variation in 
these variables was explained by the first prin-
cipal component (PC) alone. This PC demon-
strated the same association with the THs 
in the PLS regression plot as the individual 
variables (results not shown), but to avoid 
multicollinearity including all the individual 
variables in multiple regression models, indi-
vidual PC scores were included as a “common 
pregnancy-related vector.”
Individual and grouped POPs were 
included in multiple linear regression models 
based on the hierarchical cluster analysis 
(details about the grouped compounds are 
reported in the Supplemental Material, 
Section A1, “Summed contaminant groups”) 
and demonstrated that maternal TSH concen-
trations were positively associated with PFOS, 
PCB groups, and the nonachlor group (see 
Table S3). Further, there were negative 
associations among a) T3 and PCB groups, 
HCB, the nonachlor group and PFDA; b) T4 
and PCB groups, HCB, and the nonachlor 
group; c) FT4 and PCB groups; and d) FT3 
Table 1. Maternal concentrationsa of THs, TH-BPs, thyroxine-binding capacity, and maternal character-
istics (n = 370).
Variable Median (range) Mean ± SD
Study population 
reference rangeb
TSH (mlU/L) 1.55 (0.06, 10.2) 1.76 ± 1.04 0.44, 4.48
T3 (nmol/L) 2.71 (1.47, 4.75) 2.75 ± 0.46 1.97, 3.73
T4 (nmol/L) 145 (92.00, 215) 146 ± 21.1 111, 190
FT3 (pmol/L) 4.59 (2.99, 7.08) 4.62 ± 0.53 3.66, 5.79
FT4 (pmol/L) 13.0 (9.00, 20.0) 13.4 ± 1.62 10.0, 17.0
Thyroxine-binding capacityc 1.26 (0.84, 1.50) 1.26 ± 0.09 1.07, 1.43
TBG (mg/L) 36.7 (23.2, 69.6) 37.2 ± 6.74 26.2, 53.3
TTR (g/L) 0.19 (0.09, 0.27) 0.19 ± 0.03 0.15, 0.25
Albumin (g/L) 40.0 (33.9, 47.4) 40.2 ± 2.42 36.0, 46.0
Total lipid (mg/dL) 672 (344, 1,072) 672 ± 126 442, 943
Age 31 (18, 43) 31 ± 5.0
Parity 1 (0, 4) 1± 1.0
Prepregnancy body mass index 23 (17, 40) 24.0 ± 4.3
Body mass index, second trimester 25 (18, 43) 26.0 ± 4.4
Gestational week at blood sampling 18 (10, 34) 18.0 ± 3.4
Physical activity (prepregnancy)d 6.3 (1, 10) 6.0 ± 1.7
Pregnancy vectore –0.01 (–2.5, 3.2) –0.03 ± 0.9
aAnti-TPO positive women (n = 22) are included in medians. 
bStudy population reference range is defined as the 2.5th percentile (lower range) and 97.5th percentile (upper range) 
for this study population.
cUnit in TBI = thyroxine-binding index.
dReported degree of physical activity on a 1–10 point scale between very seldom to very often.
eCommon vector for pregnancy-related variables, the vector scores includes thyroxine-binding capacity, TBG, TTR, 
albumin, total lipids, and gestational week. See “Results” for details.
Table 2. Infant TSH concentrations, infant characteristics and study population specific reference range 
(n = 370).
Characteristic Boys/girls Median (range) AMa (SD)
Study population 
reference rangeb
Sex 196/174   
TSH (mlU/L)  1.20 (0.07, 7.50) 1.32 (0.94) 0.13, 3.90
Gestational length (days)  282 (212, 299) 280 (10.5)
Age at sampling (hr)  72 (48, 364) 74 (23.7)
Birth weight (g)  3,595 (1,330, 4,930) 3,626 (505)
Head circumference (cm)  36 (27, 40) 35.6 (1.46)
Length (cm)  50 (41, 57) 50.3 (2.10)
aArithmetic mean.
bStudy population reference range is defined as the 2.5th percentile (lower range) and 97.5th percentile (upper range) 
for this infant population.
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and PFUnDA. However, except for associa-
tions between PDFA and PFUnDA with T3 
and FT3 (Table 3), associations between the 
individual and grouped contaminants and 
THs or TSH were no longer significant when 
including the other contaminants as covari-
ates interchangeably. Finally, including all the 
contaminants as summed OCs (sumOCs), 
summed PFASs (sumPFASs), and summed 
OCs and PFASs (sumPOPs) in regression 
models (Table 3) demonstrated a positive 
association between sumPOPs and TSH, 
whereas sumOCs were inversely associated 
with T3, T4 and FT4.
The results from PLS regression, hierar-
chical cluster analysis, and linear regressions 
were consistent regardless of including POP 
concentrations as either ng/mL or mmol/L 
(results not shown). Further, the regres-
sion coefficients for associations between 
OCs and THs were the same regardless of 
including wet-weight or lipid-adjusted OC 
concentrations in the models. However, the 
associations between OCs and T3, T4, and 
FT4 were stronger for wet-weight than for 
lipid-adjusted concentrations. Parity and age 
were correlated with several POPs, TSH, 
and THs, and repeating the analyses when 
stratifying on parity and age groups demon-
strated the same associations between POPs 
and TSH and THs as the full models (results 
not shown). Because residual variance related 
to pregnancy-related changes could affect 
blood lipids, the analyses were repeated in a 
subset of women in gestational week 20 only 
(n = 94). In these analyses, including the OCs 
as wet-weight or lipid-adjusted concentrations 
resulted in the same regression coefficients 
(results not shown).
Associations Between Levels of 
Maternal TH and Infant TSH
The infant TSH concentrations 3 days after 
birth were positively associated with maternal 
TSH concentrations in second trimester and 
inversely associated with maternal FT4 concen-
trations 3 days postpartum (see Table S4). 
The children classified with subclinical hypo-
thyroidism had mothers within the highest 
TSH and PFOS quartile. No associations 
between maternal POP concentrations with 
infant TSH concentrations or maternal POP 




To our knowledge, this is the first multipol-
lutant study investigating thyroid disrupting 
effects of both OCs and PFASs, including 
infant TSH concentrations and as many as 
10 thyroid hormone parameters in pregnant 
women. Background exposures of POPs 
influenced maternal concentrations of TSH 
and THs, whereas infant TSH concentrations 
were associated with maternal concentrations of 
TSH and FT4. The study results contribute to a 
comprehensive understanding of the maternal 
thyroid hormone homeostasis in relation to 
current composite POP concentrations.
Associations Between 
Concentrations of POPs and 
Maternal TSH and THs
Several individual PFASs and OCs were associ-
ated with maternal TSH and THs, but only 
PFDA and PFUnDA were significantly associ-
ated with THs after adjusting for other POPs. 
We could therefore not separate the importance 
of most compounds because it is likely that they 
shared variance in TSH and TH concentrations 
in the linear regression models. Accordingly, 
including individual or grouped variables of 
PFASs, OCs, and POPs in linear regression 
models demonstrated the same overall associa-
tions with TSH and THs that is demonstrated 
by comparing Table 3 and Table S3. However, 
the associations between individual POPs, 
mainly PFOS and PCBs with TSH, were 
stronger compared with those of sumPOPs 
with TSH, and this may be explained by 
higher random variation in the latter regression 
equations. Concentrations of the PFASs were 
10-fold higher than the OCs and were highly 
correlated with the sumPOP variable (r = 0.98) 
(Table 3). This likely explains why the results 
of regressions including sumPOPs resembled 
those for sumPFASs.
Recent literature reports relevant mecha-
nisms of thyroid disruption by POPs in 
general to be a) disturbance of the overall 
activity of the thyroid gland by interference 
with the TH receptors; b) stimulation or 
inhibition of enzyme functions that mediate 
iodine uptake of the thyroid gland in the 
synthesis of T3 and T4; and c) competi-
tive displacement of THs on their binding 
proteins (Boas et al. 2012). Because the 
PFASs and OCs seem to be differentially 
associated with concentrations of THs, this 
could indicate different modes of action with 
regard to the effect of PFASs and OCs on 
the maternal thyroid homeostasis, but any 
conclusion is not feasible based solely on 
statistical associations. It has been hypoth-
esized that PFOS can alter the thyroid 
hormone levels by competitive binding to 
TH-BPs, and does not affect the regulatory 
functions of the thyroid hormone system 
itself as is demonstrated for the OCs (Chang 
et al. 2008; Lau et al. 2007). However, the 
associations between OCs and T3, T4, and 
FT4 may also reflect a compensatory feedback 
mechanism of elevated TSH levels due to 
PFASs exposure, or the opposite, where TSH 
Figure 1. Partial least squares loading plot for TSH and TH concentrations. The plot describes the linear 
relationship between the independent variables (contaminants and covariates) and the dependent 
variables (TSH and THs) and how the variables load onto the principal components. POPs circled with 
a dashed orange line were positively associated with TSH concentrations (marked with a solid orange 
circle). POPs boxed with a blue solid line were negatively associated with concentrations of T3, FT3, T4, 
and FT4 (marked with blue squares).
POPs and thyroid function in mother–child pairs
Environmental Health Perspectives • volume 125 | number 1 | January 2017 131
levels are elevated as a response to disrepancies 
in TH levels due to disruption by OCs.
The Influence of Maternal POP 
Exposures on Infant Thyroid 
Function
We did not observe associations between 
maternal POP concentrations and concentra-
tions of infant TSH. However, interpretation 
of TSH concentrations 3 days after birth in 
regard to dysregulation of infant TH homeo-
stasis may be too early to indicate thyroid 
impairment, and divergences in TH levels 
due to maternal POP exposures could develop 
throughout childhood. Indeed, associations 
between PCB concentrations in breast milk 
and TH levels in 1-year-old children have 
been demonstrated (Nagayama et al. 1998), 
and prenatal exposure to PCBs and dioxin was 
reported to be associated with subtle cognitive 
and motor developmental delays in children at 
school age (Vreugdenhil et al. 2002). Still, in a 
different study PCBs 99, 138, 153, 180, 183, 
187, 194, and 199 were positively associated 
with neonatal TSH concentrations measured 
3 days after birth (Chevrier et al. 2007), and 
concentrations of T3 in 3-week-old infants 
were inversely associated with low-chlorinated 
PCBs (Darnerud et al. 2010). The discrep-
ancies between these studies and the present 
study may be explained by different sampling 
periods between the studies, where women in 
the two previous studies (Chevrier et al. 2007; 
Darnerud et al. 2010) were sampled in the 
years 1996–2000 and had 3-fold higher POP 




Hierarchical clustering demonstrated distinct 
clusters dividing the PFASs and OCs into 
separate groups. This is in line with their 
physicochemical properties, but may also 
partly reflect the difference in their concentra-
tions and temporal trends (Nøst et al. 2013, 
2014). Stronger correlations within the OCs 
could indicate more homogeneous exposure 
to the different OCs (Lohmann et al. 2007) 
compared with the PFASs, whereas stronger 
correlations between the longest chained 
PFASs and the OCs may reflect similar recent 
exposure routes and persistence for these 
compounds. Dallaire et al. (2009) reported 
comparable correlations between PFOS and 
OCs (r = 0.36–0.55 vs. 0.25–0.45 in the 
present study) and between the different OCs 
(r = 0.69–0.98 vs. 0.54–0.95), even though 
concentrations were higher and the sampling 
was performed in 2004 in that study.
Assessing the impairment of physiological 
processes by contaminants is complicated by 
the complex correlation of exposures because 
one specific POP that is associated in a given 
study may partly or largely reflect the influ-
ence of other POPs rather than the impact 
of that POP itself. Hence, we cannot exclude 
that the observed associations between POPs 
and concentrations of TSH and THs are 
related to other contaminants (e.g., bromi-
nated flame retardants, bisphenols, and 
phthalates) not included in the statistical 
analyses. When assessing individual contami-
nants, we demonstrated significant associa-
tions between PFOS and TSH. Accordingly, 
PFOS was positively associated with TSH 
in pregnant women in Norway sampled in 
1999–2008 (Wang et al. 2013). Further, 
we demonstrated that PCBs, HCB, and 
nonachlors were inversely associated with T3, 
T4, and FT4. These results are in accordance 
with the work of Chevrier et al. (2008), who 
reported inverse associations between OCs 
(e.g., PCBs and HCB) and T4 and FT4 in 
pregnant women sampled in 1999–2000, and 
of Takser et al. (2005), who demonstrated 
inverse associations between concentrations of 
T3 and PCBs 138, 153, and 180. However, 
in the present study, the only associations 
between single contaminants and THs that 
remained significant when including the 
other contaminants as covariates were the 
associations of PFDA and PFUnDA with 
Table 3. Associationsa between serum concentrations of POPs with TSH and TH concentrations in pregnant women.
Predictors n TSH (mlU/L)b T3 (nmol/L)c T4 (nmol/L)d FT4 (pmol/L)e FT3 (pmol/L)e
Model 1: SumOCsf      
Quartile 1: 0.18–0.63 90 — Reference Reference Reference —
Quartile 2: 0.64–0.83 90 — –0.01 (–0.03, 0.01) 0.001 (–0.02, 0.02) 0.001 (–0.01, 0.02) —
Quartile 3: 0.84–1.12 91 — –0.01 (–0.03, 0.01) –0.004 (–0.02, 0.02) –0.01 (–0.02, 0.01) —
Quartile 4: 1.13–4.65 90 — –0.03 (–0.06, –0.01)* –0.02 (–0.04, –0.003)* –0.02 (–0.03, –0.001)* —
Model 2: SumPFASsg      
Quartile 1: 1.01–8.32 90 — — — — —
Quartile 2: 8.33–11.7 90 — — — — —
Quartile 3: 11.8–15.2 91 — — — — —
Quartile 4: 15.3–45.4 90 — — — — —
Model 3: SumPOPsh      
Quartile 1: 1.77–9.00 90 Reference — — — —
Quartile 2: 9.01–12.5 90 0.04 (–0.03, 0.11) — — — —
Quartile 3: 12.6–16.5 91 0.06 (–0.02, 0.14) — — — —
Quartile 4: 16.6–46.7 90 0.08 (0.001, 0.16)* — — — —
Model 4: PFDA      
Quartile 1: 0.05–0.17 90 — Reference — — —
Quartile 2: 0.18–2.3 90 — –0.01 (–0.030. 0.007) — — —
Quartile 3: 0.24–0.31 91 — –0.01 (–0.032, 0.005) — — —
Quartile 4: 0.32–2.34 90 — –0.02 (–0.044, –0.005)* — — —
Model 5: PFUnDA      
Quartile 1: 0.02–0.16 90 — — — — Reference
Quartile 2: 0.17–0.26 90 — — — — –0.01 (–0.024, 0.004)
Quartile 3: 0.27–0.38 91 — — — — –0.01 (–0.024, 0.004)
Quartile 4: 0.39–1.46 90 — — — — –0.02 (–0.033, –0.003)*
aRegression coefficient β, i.e. change in concentrations (100% × β) across quartiles with the lowest quartile as reference group.
bThe model is adjusted for parity, T-uptake (thyroxine-binding capacity), in addition to sumPFASs and sumOCs in TSH models 1 and 2, respectively. 
cThe model is adjusted for pregnancy-related change vector, parity, age, BMI, physical activity, and sumPFASs.
d The model is adjusted for pregnancy-related change vector, age, physical activity, and sumPFASs.
eThe model is adjusted for pregnancy-related change vector, age, body mass index, and sumPOPs.
fIncludes PCBs 99,118,138,153,163,170,180, and 187, p,p´-DDE, HCB, and cis- and trans-nonachlor.
gIncludes PFHpS, PFHxS, PFOA, PFOS, PFNA, PFDA, and PFUnDA.
hIncludes SumOCs and SumPFASs.
*p < 0.05, calculated for the change in concentrations compared with the reference quartile.
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T3 and FT3, respectively (Table 3). In other 
studies, authors have also been unable to 
pinpoint the individual effect of OCs on 
TH status when controlling for other OCs 
because of the high intercorrelations between 
compounds (Chevrier et al. 2008; Dallaire 
et al. 2009; Takser et al. 2005). The latter 
studies therefore also applied summed OCs 
in their statistical models. The summing 
of POP groups in the present study were 
based on intra- and intergroup correlations 
of the POPs, so we did not consider similar 
molecular mechanisms in the summing 
strategy. Finally, summing the concentra-
tions of POPs assumes equal potencies and no 
synergistic effects, which may mask effects of 
 individual compounds.
Clinical Relevance
The 95% confidence interval for the maternal 
and infant thyroid parameters varied within 
what is considered normal reference ranges 
for healthy nonpregnant and infant popu-
lations (Norwegian Association of Medical 
Biochemistry 2015), so the clinical relevance 
of the observations is not obvious. Still, 
infants born to mothers within the highest 
TSH quartile had 10% higher mean concen-
trations of TSH compared with children born 
to mothers in the lowest TSH quartile. This 
indicates an influence of maternal thyroid 
function on the infant TSH levels and could 
be a transferred effect of POP influence 
on the maternal thyroid homeostasis. Any 
disruption of maternal thyroid homeostasis 
during pregnancy and impairment in infant 
TH levels is indicated to affect infant devel-
opment according to Morreale de Escobar 
et al. (2000, 2004). Maternal hypothyroidism 
with high TSH and low FT4 levels increases 
the risk of premature birth, preeclampsia, 
low birth weight, and impaired neuropsycho-
logical development in childhood (Burman 
2009; Davis et al. 1988), whereas a decrease 
in maternal FT4 due to mild iodine deficiency 
may affect cognitive function of the offspring 
(Abalovich et al. 2007). Although a pregnant 
woman’s hypothyroidism is subclinical (mild 
and asymptomatic), it can still influence fetal 
neurodevelopment (Berbel et al. 2009).
Strengths and Limitations
Due to the complexity of the thyroid system, 
especially during pregnancy, assessment of 
potential thyroid impairment cannot be 
interpreted solely from the individual thyroid 
parameters. Therefore, we included all 
major components in the maternal thyroid 
homeostasis. To account for the adapta-
tions in metabolic processes in pregnant 
women, we performed a thorough assess-
ment of pregnancy-related covariates, and 
several influenced the variation in TSH 
and TH concentrations. As variables (e.g., 
thyroxine-binding capacity, TBG, TTR, 
lipids, and gestational week) influencing TH 
concentrations were highly correlated, they 
were included into a common pregnancy 
vector, thereby enabling us to adjust for 
all of them in multiple regressions instead 
of selecting individual ones. If these latter 
variables were not adjusted for in the statis-
tical models (individually or included in the 
vector), many more PFASs and OCs were 
significantly associated with THs. Still, many 
of these covariates are not regarded in the 
majority of studies on POPs influence on 
THs in pregnant women.
When thyroid function in pregnant 
women is evaluated, measurement of FT4 is 
recommended because free hormone reflects 
the physiological effects on thyroid hormones 
better than total hormone concentrations due 
to the pregnancy-related increases in TH-BPs 
(Fitzpatrick and Russell 2010). Still, these 
changes could also mask an actual decrease in 
levels of T3, T4, FT3, and FT4. The natural 
interference on THs by physiological changes 
during pregnancy could be reduced if all the 
pregnant women were sampled at the exact 
same gestational week. Because this was not 
possible in the present study, we included the 
TH-BPs, thyroxine-binding capacity (which 
reflects elevated levels of all the TH-BPs), 
lipids, and gestational week as a proxy for 
the pregnancy-related alterations in blood 
in statistical models. This was supported by 
repeated analyses of subsets of women in 
gestational week 18 and 20 where the associa-
tions from full models were confirmed.
The wet-weight concentrations of OCs 
were used in the regression models to be 
comparable with the PFAS wet-weight 
concentrations. Due to the mutual depen-
dency between OCs and THs with lipids 
(results not shown), we chose to use the 
wet weight concentrations in the regres-
sion models for THs. Further, total lipids 
were adjusted for in models included in the 
pregnancy vector; an additional adjustment 
for lipids of the OCs was not performed 
because it would probably have led to over-
adjustments. This was confirmed in analyses 
performed on women in gestational week 20, 
where the effect of pregnancy-related variables 
was assumed to be similar, and where using 
either wet-weight or lipid-adjusted concentra-
tions gave the same regression coefficients.
An important problem in multiple statis-
tical comparisons is that the probability of 
wrongly concluding that there is at least one 
statistically significant effect across a set of 
tests increases with each additional test 
(Gelman et al. 2012). To minimize multiple 
comparisons, regression models in the present 
study were built on the overall associations 
from one PLS-regression model and not from 
several simple linear regression models.
Conclusions
The present study suggests that background 
exposure of POPs can alter thyroid hormone 
homeostasis in pregnant women, subsequently 
affecting the infant thyroid system. Our results 
highlight the challenges of assessing effects 
on thyroid function, especially during preg-
nancy, due to the complexity of contaminant 
mixtures and the thyroid system. However, 
regarding the critical role of maternal thyroid 
hormones in fetal development, associations 
between maternal thyroid homeostasis with 
individual, grouped, or summed POPs are of 
great public health importance.
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